Common Contracts

GRANT AGREEMENT

Agreement • August 16th, 2023

• Contract Type
  Agreement
• Filed
  August 16th, 2023

This Agreement (“Agreement”), effective as of April 19th 2023, is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and Sjældne Diagnoser (“Organization”) (collectively, the “Parties”).

GRANT AGREEMENT

Agreement • August 12th, 2022

• Contract Type
  Agreement
• Filed
  August 12th, 2022

This Agreement (“Agreement”), effective as of 12 August 2022, is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and Patientforeningen Lungekræft, Industrivej 21, 4000 Roskilde (“Organization”) (collectively, the “Parties”).

Contract

Agreement ( • July 6th, 2021

• Contract Type
  Agreement (
• Filed
  July 6th, 2021

This Agreement (“Agreement”), effective as of 12th July 2021, is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and Patientforeningen Lungekræft, Industrivej 21, 4000 Roskilde, Danmark (“Organization”) (collectively, the “Parties”).

GRANT AGREEMENT

Agreement • March 26th, 2021

• Contract Type
  Agreement
• Filed
  March 26th, 2021

This Agreement (“Agreement”), effective as of 26th March 2021, is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and Colitis-Crohn Foreningen (“Organization”) (collectively, the “Parties”).